54
Participants
Start Date
July 26, 2018
Primary Completion Date
March 12, 2020
Study Completion Date
June 9, 2020
Prednisone
40 mg (8 x 5mg tablets) for three consecutive days, then 30 mg (6 x 5mg tablets), 20 mg (4 x 5 mg tablets), 10 mg (2 x 5 mg tablets) and 5 mg (1 x 5 mg tablet) daily for two consecutive days for each dose level for a total of 11 days of treatment.
Placebo
8 tablets for 3 consecutive days; then 6 tablets, 4 tablets, 2 tablets, and 1 tablet daily for 2 consecutive days for each tablet count for a total of 11 days
Innovaderm Research Inc., Montreal
Lead Sponsor
Innovaderm Research Inc.
OTHER